CORDIS · 951459 · H2020
HiSCORE Highly Informative Drug Screening by Overcoming NMR Restrictions
Coordinator: ECOLE NORMALE SUPERIEURE (FR)
The need for drug screening with increasingly higher throughput is dictated both by the increasing number of drug targets made available through genomics and the increasing number of chemical molecules generated through combinatorial chemistry. Merely Boolean high-throughput screening techniques today can scan large compound libraries, but the ever increasing throughput has not translated into a significant increase in late-phase drug candidates. HiSCORE presents a synergistic approach to high-throughput, high-information drug screening that builds on the complementary skills of four laborato…
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
EU contribution: €14.0M awarded to the consortium. The project runs over approximately 6 years from 2021-05-01 to 2027-04-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from FR
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FP7 · €250.0M
- PARC — Partnership for the Assessment of Risks from Chemicals101057014 · HORIZON · €200.0M
- Biodiversa-plus — The European Biodiversity Partnership101052342 · HORIZON · €105.0M
- OFELIA — Open Fan for Environmental Low Impact of Aviation101102011 · HORIZON · €100.0M
- EPI SGA1 — SGA1 (Specific Grant Agreement 1) OF THE EUROPEAN PROCESSOR INITIATIVE (EPI)826647 · H2020 · €80.0M
- Water4All — Water4All – Water Security for the Planet101060874 · HORIZON · €56.9M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the ERC-SyG funding scheme.
- What is the EU contribution?
- The European Commission contributes €14.0M toward a total project budget of €14.0M.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call ERC-2020-SyG.
- Who coordinates the project?
- The project is coordinated by ECOLE NORMALE SUPERIEURE (FR).
- What is the project timeline?
- The project runs from 2021-05-01 to 2027-04-30 — approximately 6 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 951459.